Open AccessTherapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+CTL-mediated cytotoxicity in HLA-A2+human PBMCs
Author(s) -
Tongdong Shi
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i13.1902
Subject(s) - epitope , ctl* , immunogenicity , cytotoxic t cell , cd8 , peripheral blood mononuclear cell , virology , t cell , antigen , hbcag , cytotoxicity , human leukocyte antigen , biology , hepatitis b virus , immunology , microbiology and biotechnology , immune system , in vitro , hbsag , virus , biochemistry
To explore how to improve the immunogenicity of HBcAg CTL epitope based polypeptides and to trigger an HBV-specific HLA I-restricted CD8+ T cell response in vitro.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom